Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4475
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or “the company”) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ionis Pharmaceuticals, Inc.: Company Overview 9
Ionis Pharmaceuticals, Inc.: Overview and Key Facts 9
Ionis Pharmaceuticals, Inc.: Overview 9
Ionis Pharmaceuticals, Inc.: Key Facts 9
Ionis Pharmaceuticals, Inc.: Key Employees 11
Ionis Pharmaceuticals, Inc.: Key Employee Biographies 12
Ionis Pharmaceuticals, Inc.: Major Products and Services 15
Ionis Pharmaceuticals, Inc.: Company History 16
Ionis Pharmaceuticals, Inc.: Management Statement 21
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries 24
Ionis Pharmaceuticals, Inc.: Key Competitors 25
Ionis Pharmaceuticals, Inc.: Company Analysis 26
Ionis Pharmaceuticals, Inc.: Business Description 26
Ionis Pharmaceuticals, Inc.: SWOT Analysis 27
Ionis Pharmaceuticals, Inc.: SWOT Overview 27
Ionis Pharmaceuticals, Inc.: Strengths 27
Ionis Pharmaceuticals, Inc.: Weaknesses 28
Ionis Pharmaceuticals, Inc.: Opportunities 28
Ionis Pharmaceuticals, Inc.: Threats 29
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31
Ionis Pharmaceuticals, Inc.: Financial Deals Overview 31
Ionis Pharmaceuticals, Inc.: Targets and Partners 33
Ionis Pharmaceuticals, Inc.: Top Deals 2014 – 2018YTD* 35
Ionis Pharmaceuticals, Inc.: Advisors 36
Ionis Pharmaceuticals, Inc.: Top Legal Advisors 36
Ionis Pharmaceuticals, Inc.: Top Financial Advisors 36
Ionis Pharmaceuticals, Inc.: Corporate Venturing 37
Ionis Pharmaceuticals, Inc.: Capital Raising 38
Ionis Pharmaceuticals, Inc.: Partnership 39
Ionis Pharmaceuticals, Inc.: Divestments 40
Ionis Pharmaceuticals, Inc.: Private Equity and Ownership 41
Ionis Pharmaceuticals, Inc.: Recent Developments 42
Ionis Pharmaceuticals, Inc.: News and Events Summary 42
Ionis Pharmaceuticals, Inc.: Corporate Governance 45
Ionis Pharmaceuticals, Inc.: Financial Performance 46
Ionis Pharmaceuticals, Inc.: Market Developments 46
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events 48
Ionis Pharmaceuticals, Inc.: Strategy and Operations 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance
Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 24: Ionis Pharmaceuticals, Inc.: Market Developments
Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 26: Ionis Pharmaceuticals, Inc.: Strategy and Operations

List of Figures
Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 11: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Visioneering Technologies Inc:製品パイプライン分析
    Summary Visioneering Technologies Inc (VTI) is a medical device company that develops and commercializes on-eye and in-eye solutions for presbyopia, astigmatism and myopia progression control. The company offers technology consists of myopia correction technology, silicone hydrogel material platform …
  • 1414 Degrees Ltd (14D):企業の財務・戦略的SWOT分析
    1414 Degrees Ltd (14D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cosmo Films Ltd:戦略・SWOT・企業財務分析
    Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • WPG Resources Ltd (WPG):企業の財務・戦略的SWOT分析
    Summary WPG Resources Ltd (WPG) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, nickel, base metals, iron ore, and coal properties in South Australia. Its projects comprise Tunkillia gold project, Tarcoola gold …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wynn Resorts Ltd:戦略・SWOT・企業財務分析
    Wynn Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • LeasePlan Corporation N.V.:戦略・SWOT・企業財務分析
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Dome Energy AB (DOME):石油・ガス:M&Aディール及び事業提携情報
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • Fred’s, Inc.:戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sirius International Insurance Corp:企業の戦略・SWOT・財務分析
    Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report Summary Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Columbia Power Corporation:企業の戦略的SWOT分析
    Columbia Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cytox Ltd-医療機器分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆